Free Trial

Resverlogix (RVX) Insider Trading & Ownership

Resverlogix logo
C$0.06 0.00 (0.00%)
(As of 11/20/2024 ET)

Resverlogix (TSE:RVX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
42.66%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
C$38,000.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get RVX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Resverlogix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RVX Insider Buying and Selling by Quarter

Resverlogix Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/27/2022Donald J. MccaffreyDirectorBuy9,500C$0.25C$2,375.00
6/24/2022Donald J. MccaffreyDirectorBuy91,000C$0.25C$22,750.00
6/22/2022Donald J. MccaffreyDirectorBuy3,000C$0.25C$750.00
6/16/2022Donald J. MccaffreyDirectorBuy500C$0.25C$125.00
6/14/2022Donald J. MccaffreyDirectorBuy24,000C$0.25C$6,000.00
6/14/2022Donald J. MccaffreyDirectorBuy24,000C$0.25C$6,000.00
(Data available from 1/1/2013 forward)

RVX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Resverlogix includes Donald J. Mccaffrey. Learn more on insiders at RVX.

42.66% of Resverlogix stock is owned by insiders. Learn more on RVX's insider holdings.

Resverlogix Key Executives

  • Mr. Donald J. McCaffrey
    Co-Founder, Chairman, President, CEO & Secretary
  • Mr. Aaron Bradley Cann C.A.
    CPA, CBV, Chief Financial Officer
  • Dr. Ewelina Kulikowski Ph.D.
    Chief Scientific Officer
  • Dr. Michael Sweeney M.D. (Age 63)
    Senior Vice President of Clinical Development
    Compensation: $511.56k
  • Sarah Zapotichny
    Director of Investor Relations & Corporate Communications


This page (TSE:RVX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners